Safety After Oral Intake: Clinical Trials

8 trials for Safety After Oral Intake, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 not yet recruiting, 1 recruiting. 3 Early Phase 1, 2 Not applicable, 2 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Early Phase 13Completed 3
Not applicable2Completed 2
Phase 12Completed 1, Not yet recruiting 1
Phase 41Recruiting 1

Follow Safety After Oral Intake: new trials by email Literature Review of Safety After Oral Intake trials Research Report on Safety After Oral Intake

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants
MDI-2517 800mg, Placebo, MDI-2517 1600mg - Safety After Oral Intake
Phase 1CompletedMDI Therapeutics, Inc.322025-11-042026-05-22
Effects of Energy Drinks on Cardiovascular Endpoints
Energy Drink A + Placebo Capsule, Placebo Drink + Moxifloxacin Capsule, Placebo Drink + Caffeine Capsule - Healthy Volunteers, Safety After Oral Intake
Phase 4RecruitingUniversity of the Pacific32025-11-012025-11-26
A Research Study to Evaluate BLX-7006 in Healthy Adults
BLX-7006, Placebo - Normal Healthy Volunteer, Safety After Oral Intake
Phase 1Not yet recruitingBiolexis Therapeutics762025-09-012025-08-24
Chrysin Bioavailability and Safety
LipoMicel Chrysin, Non-Micellar Chrysin, Standard/Unformulated Chrysin - Bioavailability and Pharmacokinetics, Safety After Oral Intake
Not applicableCompletedIsura182024-12-052025-07-15
Comparison of Curcumin Bioavailability
Native turmeric extract, Native turmeric extract with 7-9% volatile turmeric oils, Turmeric extract plus mixture of phytochemicals - Safety After Oral Intake, Pharmacokinetics After Oral Intake
Not applicableCompletedUniversity of Hohenheim122018-06-072019-01-10
Absorption and Excretion Kinetics of the Bioactive Ingredients of Rice Bran Extract
Rice bran extract, Porridge in water, Porridge in milk - Safety After Oral Intake, Pharmacokinetics After Oral Intake
Early Phase 1CompletedUniversity of Hohenheim122016-04-012017-05-03
Oral Bioavailability and Bioactivity of Prenylflavonoids From Hops
Placebo, 6-prenylnaringenin, 8-prenylnaringenin - Safety After Oral Intake, Pharmacokinetics After Oral Intake
Early Phase 1CompletedUniversity of Hohenheim162016-01-012018-03-30
Bioavailability of Resveratrol From Vineatrol30 Extract Incorporated Into Micelles
Vineatrol 30 native powder, Vineatrol 30 micelles - Safety After Oral Intake, Pharmacokinetics After Oral Intake
Early Phase 1CompletedUniversity of Hohenheim122015-03-012017-05-03

Narrower conditions

Diabetes Mellitus, Type 2 (1)  ·  Metabolic Diseases (1)  ·  Obesity (1)

Broader conditions

Body Weight (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

6-prenylnaringenin (1)  ·  8-prenylnaringenin (1)  ·  Caffeine (1)  ·  Control Groups (1)  ·  Milk (1)  ·  Moxifloxacin (1)  ·  Rice Bran Oil (1)  ·  Taurine (1)  ·  Water (1)  ·  turmeric extract (1)

Sponsors

University of Hohenheim (4)  ·  Biolexis Therapeutics (1)  ·  Isura (1)  ·  MDI Therapeutics, Inc. (1)  ·  University of the Pacific (1)

Countries

Germany (4)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)

Top investigators

Jan Frank, Prof. Dr (2)  ·  Jan Frank, Prof. Dr. (2)  ·  Christian Busch, Dr. med. (1)  ·  David Wyatt, MD (1)  ·  Julia Solnier, PhD (1)  ·  Sascha Venturelli, Dr. med. Dr. rer. nat. (1)

Results publications

PMID 29363261